A detailed history of Gateway Advisory, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gateway Advisory, LLC holds 40,463 shares of MRK stock, worth $3.97 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
40,463
Previous 39,943 1.3%
Holding current value
$3.97 Million
Previous $4.94 Million 7.08%
% of portfolio
0.82%
Previous 0.93%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $57,798 - $67,064
520 Added 1.3%
40,463 $4.59 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $122,314 - $131,364
988 Added 2.54%
39,943 $4.94 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $354,780 - $413,399
3,133 Added 8.75%
38,955 $5.14 Million
Q4 2023

Feb 07, 2024

BUY
$100.18 - $109.02 $3.3 Million - $3.59 Million
32,916 Added 1132.69%
35,822 $3.91 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $25,222 - $28,010
245 Added 9.21%
2,906 $299,000
Q2 2023

Aug 10, 2023

SELL
$108.61 - $118.38 $17,051 - $18,585
-157 Reduced 5.57%
2,661 $307,000
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $30.6 Million - $34.1 Million
-297,012 Reduced 99.06%
2,818 $300,000
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $30.6 Million - $34.1 Million
297,013 Added 10543.59%
299,830 $300,000
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $87 - $112
1 Added 0.04%
2,817 $313,000
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $14,031 - $15,763
166 Added 6.26%
2,816 $243,000
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $83 - $94
1 Added 0.04%
2,650 $242,000
Q1 2022

Apr 21, 2022

BUY
$73.51 - $82.4 $194,727 - $218,277
2,649 New
2,649 $217,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Gateway Advisory, LLC Portfolio

Follow Gateway Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Advisory, LLC with notifications on news.